Lipocine Inc.
Lipocine Inc. (LPCN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lpcn · stock forecast · 9 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$15.00
Consensus
$10.50
+414.7% upside
Low
$6.00
Median: $10.5 · Last Close: $2.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$10.50
414.7% upside
High Target
$15
635.3%
Low Target
$6
194.1%
Current Price
$2.04
as of today
Based on analyst price targets, the LPCN stock price prediction for the next 12 months ranges from $6 to $15. The consensus LPCN price forecast of $10.50 implies 414.7% upside from the current price of $2.04.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.00 | ↓ 2.20% |
1-day model range: $1.98–$2.01. Peak: $2.01 (-2.20%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · LPCN · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-07-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-08-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-06-24 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-05-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Lipocine Inc. (LPCN) stock. Of the recent 20 rating actions, 2 were upgrades and 2 were downgrades. 9 analysts currently cover LPCN.
Analyst Recommendation Trends
LPCN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 51.0% YoY
Revenue Next Year
$1M
↑ 85.4% YoY
EPS This Year
$-1.91
EPS Next Year
$-1.65
↓ 13.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast LPCN EPS of $-1.91 for the current fiscal year, based on estimates from 1 analysts. The LPCN revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LPCN stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LPCN price target is $10.50 (+414.7% upside), with an analyst consensus of Buy.
The LPCN short-term stock prediction for tomorrow is $2.00 (-2.20%).
Lipocine Inc. trades on NASDAQ under the ticker LPCN. The LPCN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 78% of covering analysts.
Frequently asked questions
LPCN forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month LPCN price target is $10.50, with a high forecast of $15.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +414.7% potential upside from the current price of $2.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.